Sunday, May 22, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Severe symptoms result in high titers of SARS-CoV-2 antibodies

by Medical Finance
in Coronavirus
Study: Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19. Image Credit: peterschreiber.media/ / Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the novel coronavirus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has drastically affected the global healthcare system and economy. SARS-CoV-2 causes asymptomatic to severe infection, which sometimes results in death. Scientists observed that active replication of the virus occurs in the early stage of the infection, whereas the host immune system critically functions in the later phase of the infection. This is why researchers strategized on using antiviral agents to target SARS-CoV-2 at its early stage of infection.

Study: Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19. Image Credit: peterschreiber.media/ / ShutterstockStudy: Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19. Image Credit: peterschreiber.media/ / Shutterstock

Background

Several studies have assessed the host immune response along with the COVID-19 disease progression. These studies have stated that although the immune system plays a vital role in protecting an individual from the disease, overpowering immune responses, e.g., cytokine storm, negatively affect the host.

Scientists stated that the role of antibody-based immune responses in COVID-19 disease is not well understood. Prior studies have correlated severely infected individuals with COVID-19 with high levels of SARS-CoV-2 antibodies. However, it is not well understood if high titers of SARS-CoV-2 antibodies exacerbate the clinical outcome of the disease, or if severe illness results in the production of a high concentration of antibodies.

A New Study

Addressing the above-mentioned research gap, scientists have focused on determining the cause-effect relationship between SARS-CoV-2 antibody titers and COVID-19 disease severity. The study is published in the Journal of Microbiology, Immunology and Infection.

In this study, researchers recruited hospitalized COVID-19 patients between February 2020 and August 2020. They measured neutralizing antibody (NAb) and anti-receptor-binding domain (RBD) antibodies from the blood samples obtained from the participants. The scientists further estimated the chest radiograph (CXR) scores to determine the severity of the disease.

Key Findings

The study reported a high titer of antibodies in elderly patients with COVID-19. These patients suffered from pneumonia and needed oxygen support. Scientists compared the peak time of COVID-19 antibody levels and CXR scores and observed that CXR scores maximized significantly earlier than NAb and anti-RBD antibody titers. Since a direct correlation was found between the highest CXR score and the highest level of SARS-CoV-2 specific antibodies, the authors concluded that the production of high antibody titers resulted from severe clinical outcomes.

Typically, when a human body is invaded by a pathogen (e.g., a virus), the innate and adaptive immune system protects from the virus. Several studies have indicated that the cellular immune system is involved in clearing pathogens from the body, while humoral immunity primarily protects against new infection.

As prior studies have linked a high production of SARS-CoV-2 antibodies with the manifestation of severe disease or mortality, it has led to a perception that overwhelming production of SARS-CoV-2 antibodies promotes disease progression via antibody-dependent enhancement (ADE). Similar observations have been recorded for the dengue virus. Interestingly, studies related to assessing the efficacy of convalescent plasma therapy for COVID-19 patients revealed no adverse effects when the patients were treated with a high titer of SARS-CoV-2 antibodies. Furthermore, animals immunized with the COVID-19 vaccine did not exhibit any signs of ADE. These findings prove that ADE is not the possible cause of COVID-19 disease progression. 

Scientists believe that uncontrolled replication of the virus and hyperinflammatory conditions could be the reason for the production of high levels of SARS-CoV-2 antibodies in severely infected COVID-19 patients. In this study, the scientists speculated that high levels of NAb and anti-RBD antibodies were elicited owing to a high viral load, dysregulated immune responses, and uncontrolled viral replication in severely infected patients.

The study reported that elderly patients exhibited a higher level of SARS-CoV-2 antibodies compared to younger patients. This result implies that elderly patients are more vulnerable to severe infection due to the production of high titer of SARS-CoV-2 antibodies. Although researchers studied the changes in the proinflammatory cytokines, the results were obtained for only fifteen patients. This is the reason why they failed to draw a robust conclusion regarding the association between proinflammatory cytokines, T- and B-cell immunity, and COVID-19 disease severity. Future research should make use of a larger sample size to determine whether these relationships exist.

Conclusion

The authors highlighted some of the limitations of the study, which include its relatively small study cohort containing participants from a single hospital. They did not measure the neutralization capability of the SARS-CoV-2 antibody, and as a result, they failed to confirm if a high concentration of Nab has a more significant effect on the neutralization of the SARS-CoV-2 virus. In this study, high titers of SARS-CoV-2 antibodies were strongly related to severe COVID-19 manifestation. Understanding the underlying mechanisms behind such an association would be a crucial step toward developing novel vaccines and therapeutics to prevent, cure, and treat SARS-CoV-2 infections.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

Common coronavirus infections don’t generate antibodies that effectively cross-react with SARS-CoV-2

by Medical Finance
May 22, 2022
0

Although SARS-CoV-2 has taken the world by storm, it's not the only coronavirus that can infect humans. But unlike SARS-CoV-2,...

Study: SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13. Image Credit: Juan Gaertner/Shutterstock

Study sheds light on biomechanistic reasons why allergic asthma correlates with milder forms of COVID-19

by Medical Finance
May 22, 2022
0

An exciting study recently published in the Proceedings of the National Academy of Sciences (PNAS) underscores the role of a...

Study: Founder effect contributes to the unique pattern of SARS-CoV-2 variant B.1.1.519 emergence in Alaska. Image Credit: Paranyu/Shutterstock

Genomic sequencing reveals unique pattern of SARS-CoV-2 Epsilon emergence in Alaska

by Medical Finance
May 22, 2022
0

In a recent study posted to the medRxiv* pre-print server, researchers used genomic sequencing to examine severe acute respiratory syndrome...

Study: A Nonextensive View on the COVID-19 in the World. Image Credit: Viacheslav Lopatin/Shutterstock

Novel non-extensive statistical model to study COVID-19 epidemic distribution

by Medical Finance
May 22, 2022
0

In a new study posted to the Research Square* preprint server and under consideration at Scientific Reports, researchers modified and...

Study: Getting to the (germinal) center of humoral immune responses to SARS-CoV-2. Image Credit: Lightspring/Shutterstock

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

by Medical Finance
May 22, 2022
0

In two recent papers published in the journal Cell, researchers explored the germinal center (GC) of antibody (Ab)-mediated immunity towards...

Study: Bacterial and Fungal Isolation from Face Masks: Newly Emerged Hygiene Issues Under COVID-19 Pandemic. Image Credit: fizkes/Shutterstock

Newly emerged-hygiene issue in the current lifestyles of wearing face masks during the COVID-19 pandemic

by Medical Finance
May 22, 2022
0

A recent article posted to the Research Square* preprint server and under consideration at Scientific Reports evaluated a novel hygiene concern...

Next Post
Nutritional components hold promise for improving the health and well-being of adults

Molecular RNA profile of naked mole-rats reveals new insights on skin aging

Study: Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease. Image Credit: SKK Pix / Shutterstock

Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: The mechanism of RNA capping by SARS-CoV-2. Image Credit: Design_Cells / Shutterstock
    RNA capping mechanism of SARS-CoV-2 unveiled
  • Chemo Vials 620x480
    Study opens the door to a new approach to attacking herpesviruses
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply